Curcumin Promotes Diabetic Foot Ulcer Wound Healing by Inhibiting MiR-152-3p and Activating the FBN1/TGF-β Pathway
Overview
Molecular Biology
Affiliations
The objective of this study was to investigate the mechanism of curcumin in diabetic foot ulcer (DFU) wound healing. A DFU rat model was established, and fibroblasts were cultured in a high-glucose (HG) environment to create a cell model. Various techniques, including Western blot, RT‒qPCR, flow cytometry, Transwell, cell scratch test and H&E staining, were employed to measure the levels of relevant genes and proteins, as well as to assess cell proliferation, apoptosis, migration, and pathological changes. The results showed that miR-152-3p was overexpressed in DFU patients, while FBN1 was underexpressed. Curcumin was found to inhibit fibroblast apoptosis, promote proliferation, migration, and angiogenesis in DFU rats, and accelerate wound healing in DFU rats. In addition, overexpression of miR-152-3p weakened the therapeutic effect of curcumin, while overexpression of FBN1 reversed the effects of the miR-152-3p mimic. Further investigations into the underlying mechanisms revealed that curcumin expedited wound healing in DFU rats by restoring the FBN1/TGF-β pathway through the inhibition of miR-152-3p. In conclusion, curcumin can suppress the activity of miR-152-3p, which, in turn, leads to the rejuvenation of the FBN1/TGF-β pathway and accelerates DFU wound healing.
The role of platelet-rich plasma in biomedicine: A comprehensive overview.
Zhang Z, Liu P, Xue X, Zhang Z, Wang L, Jiang Y iScience. 2025; 28(2):111705.
PMID: 39898035 PMC: 11787504. DOI: 10.1016/j.isci.2024.111705.
Bibliometric Analysis of Curcumin Based on CiteSpace: Landscapes, Hotspots, and Frontiers.
Lai Y, Jiang J, Zhang H, Gong K Drug Des Devel Ther. 2024; 18():5743-5758.
PMID: 39659947 PMC: 11630724. DOI: 10.2147/DDDT.S494758.
The emerging modulators of non-coding RNAs in diabetic wound healing.
Aghayants S, Zhu J, Yu J, Tao R, Li S, Zhou S Front Endocrinol (Lausanne). 2024; 15:1465975.
PMID: 39439564 PMC: 11493653. DOI: 10.3389/fendo.2024.1465975.
Alternative Cancer Therapeutics: Unpatentable Compounds and Their Potential in Oncology.
Ovcharenko D, Mukhin D, Ovcharenko G Pharmaceutics. 2024; 16(9).
PMID: 39339273 PMC: 11435428. DOI: 10.3390/pharmaceutics16091237.
Role of Curcuma longae Rhizoma in medical applications: research challenges and opportunities.
Zhang P, Liu H, Yu Y, Peng S, Zhu S Front Pharmacol. 2024; 15:1430284.
PMID: 39170702 PMC: 11336575. DOI: 10.3389/fphar.2024.1430284.